Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polysaccharide superparamagnetic iron oxide injection MRI study in healthy subjects
NCT06010537Phase 1Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Apr 2021
- Primary completion
- Apr 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ferumoxytol (2 arms), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Primary endpoint: Adverse event rate. Started Apr 2021; status: completed.
02
Drugs
ferumoxytol
Beyond the preview
Go deeper on NCT06010537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06010537.